Form 4: Medpace Holdings CEO August J. Troendle Sells Shares

Medpace Holdings CEO August J. Troendle reports selling shares of the company's common stock on May 6th and 7th, 2024.

Summary

• August J. Troendle, CEO of Medpace Holdings, Inc., reported the sale of company stock.
• On May 6, 2024, 24,372 shares of common stock were sold at a weighted average price of $401.73, with prices ranging from $400.00 to $404.94.
• Following this transaction, Troendle directly owns 749,011 shares.
• On May 7, 2024, an additional 28,032 shares were sold at a weighted average price of $404.48, with prices ranging from $400.00 to $408.62.
• Following this transaction, Troendle directly owns 720,979 shares.
• Troendle also indirectly owns 4,733,019 shares through Medpace Investors, LLC.
• The sales were executed pursuant to a limit order placed during an open window period.

Sentiment

Score: 5

Explanation: This is a neutral disclosure of stock sales by the CEO. It doesn't inherently indicate positive or negative sentiment about the company's future.

Industry Context

This filing is a routine disclosure of insider trading activity. It's common for executives to periodically sell shares for personal financial management.

Stakeholder Impact

• The stock sale could have a minor impact on shareholders, potentially causing a slight decrease in stock price due to increased supply.

Key Dates